Aristo Bio-Tech Reports H1 Results Ending 30th Sep'26
Aristo Bio-Tech & Lifescience Ltd · Outcome · 15 Nov 2026, 2:09 am
Aristo Bio-Tech Reports H1 Results Ending 30th Sep'26 Aristo Bio-Tech and Lifescience reported standalone revenue from operations of ₹19,824.17 lakh for the half-year ended 30th Sep'26, down 22.7% YoY from ₹25,645.31 lakh in the period ended 30th Sep'25. Net profit rose 17.6% YoY to ₹490.19 lakh from ₹416.96 lakh, supported by lower material costs of ₹17,787.33 lakh. Profit before tax stood at ₹659.84 lakh versus ₹554.44 lakh YoY. Basic and diluted EPS improved to ₹7.20 from ₹6.12 YoY. Net operating cash flow for the period stood at ₹241.51 lakh.
Original exchange filing (PDF)
More announcements from Aristo Bio-Tech & Lifescience Ltd
- Aristo Bio-Tech And Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- Aristo Bio-Tech and Lifescience Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 14 Nov 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Re-Appointment of Ms. Rashmi Kamlesh Otavani as Non- Executive Independent Director of the company w.e.f. March 20, 2027. · 02 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Appointment of Mr Ketankumar Harkantbhai Modi as whole Time Director of the company w.e.f. March 20, 2027. · 02 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. · 02 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026. · 01 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding 'Web-link of Annual Report for Financial Year 2025-26 to those Members who have not registered their e-mail addresses'. · 11 Sept 2026
